Masahide Nakajima
Overview
Explore the profile of Masahide Nakajima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suzuki S, Suzuki K, Furukawa T, Nakajima M, Sakai H
Intern Med
. 2023 Oct;
63(9):1317-1322.
PMID: 37839888
Izumi fever (IF), also known as Far East scarlet-like fever (FESLF), is caused by Yersinia pseudotuberculosis and it has clinical features resembling those of Kawasaki disease (KD). As both diseases...
2.
Ichikawa T, Torii S, Suzuki H, Takada A, Suzuki S, Nakajima M, et al.
Int J Infect Dis
. 2022 May;
122:123-129.
PMID: 35562044
Background: From late March through April 2021, we experienced a cluster of patients with COVID-19, named "Cluster K", with rapid severe illness compared with those who were infected before. Methods:...
3.
Higashi Y, Miyata T, Shigematsu H, Origasa H, Fujita M, Matsuo H, et al.
Circ J
. 2019 Jul;
83(9):1929-1936.
PMID: 31292312
Background: Guidelines for peripheral arterial disease (PAD) recommend long-term antiplatelet therapy in symptomatic patients to reduce cardiovascular morbidity and mortality risk. Although diabetes is a known risk factor for PAD,...
4.
Miyata T, Higashi Y, Shigematsu H, Origasa H, Fujita M, Matsuo H, et al.
Angiology
. 2018 Nov;
70(6):506-514.
PMID: 30477334
Surveillance of cardiovascular Events in Antiplatelet-treated arterioSclerosis Obliterans patients in JapaN (SEASON) is a 2-year, prospective, real-world, registry study conducted in Japan from 2009 to 2013. This post hoc analysis...
5.
Ukeba-Terashita Y, Kobayashi R, Hori D, Matsushima S, Sano H, Suzuki D, et al.
Pediatr Blood Cancer
. 2018 Oct;
66(2):e27478.
PMID: 30350912
Background: Stem cell transplantation (SCT) outcomes have improved over the last three decades, with many patients being rescued with this treatment. However, improved outcomes have led to issues with long-term...
6.
Namatame-Ohta N, Morikawa S, Nakamura A, Matsuo K, Nakajima M, Tomizawa K, et al.
Case Rep Pediatr
. 2018 Aug;
2018:6561952.
PMID: 30073107
Almost 90% of nephrogenic diabetes insipidus (NDI) is caused by mutations in the arginine vasopressin receptor 2 gene () on the X chromosome. Herein, we reported clinical and biochemical parameters...
7.
Higashi Y, Miyata T, Shigematsu H, Origasa H, Fujita M, Matsuo H, et al.
Sci Rep
. 2017 Jul;
7(1):6095.
PMID: 28733607
The present analysis was intended to evaluate the real-world management of peripheral arterial disease (PAD) in Asia, and to explore cardiovascular events in patients with PAD undergoing antiplatelet therapy over...
8.
Higashi Y, Miyata T, Shigematsu H, Origasa H, Fujita M, Matsuo H, et al.
Circ J
. 2016 Feb;
80(3):712-21.
PMID: 26841805
Background: Despite mounting evidence of increased cardiovascular events in patients with peripheral arterial disease (PAD), the overall incidence of cardiovascular events in PAD patients has not been fully clarified in...
9.
Kanno K, Sakai H, Nakajima M, Satake A, Konishi T, Iizuka H
Case Rep Dermatol
. 2011 May;
3(1):98-102.
PMID: 21577371
Kawasaki disease is an acute febrile disease predominantly seen in young children. We report a case of Kawasaki disease in a 32-year-old pregnant woman. She developed a generalized erythematous skin...
10.
Ichikawa M, Kobayashi R, Nakajima M, Inamoto J, Suzuki D, Cho Y, et al.
J Pediatr Hematol Oncol
. 2011 Mar;
33(4):e143-8.
PMID: 21423043
The rapidity of response to induction therapy is emerging as an important prognostic factor in children with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Urine inorganic phosphate (IP)...